CD8A and lung carcinoma: The CD4/CD8 ratio in normal individuals ranges from 1.5 to 2.5, and the low or inverted ratio is associated with altered immune function, immune senescence and chronic inflammation, as well as a variety of diseases, like neurocognitive disorders, lung cancer, and chronic obstructive pulmonary disease [30–37].